Duration of Apixaban (Eliquis) After Blood Clot
For most patients with a blood clot, take Eliquis for at least 3-6 months initially, then continue indefinitely at a reduced dose (2.5 mg twice daily) if the clot was unprovoked or you have ongoing risk factors. 1, 2
Initial Treatment Phase (First 3-6 Months)
Start with 10 mg twice daily for 7 days, then reduce to 5 mg twice daily for the remainder of the initial treatment period 3. This initial phase treats the acute clot and prevents early recurrence.
- Minimum duration: 3 months for all venous blood clots 1, 4, 2
- Optimal duration: 3-6 months for unprovoked clots (no clear trigger) 4, 2
- Consider stopping at 3 months if your clot was clearly provoked by a major temporary risk factor like surgery or major trauma that has resolved 1, 2
Extended Treatment (Beyond 6 Months)
After completing initial treatment, the decision depends on what caused your clot:
Continue Indefinitely If:
- Unprovoked clot (no identifiable cause) - annual recurrence risk exceeds 5% without anticoagulation 1, 4, 2
- Persistent risk factors like active cancer, ongoing chemotherapy, or chronic medical conditions 1, 5, 2
- Recurrent clots - especially strong indication for lifelong therapy 1, 2
For extended treatment, use reduced-dose Eliquis 2.5 mg twice daily rather than the full 5 mg dose 1, 2. This provides 10 fewer bleeding events per 1,000 patients with only 2 additional clot events per 1,000 patients 1.
Stop After 3-6 Months If:
- Major surgery or trauma that triggered the clot and has fully resolved 1, 2
- Temporary medical illness that has resolved 1, 2
- Hormone-related (birth control pills, hormone replacement) if you've stopped the hormones 4
Special Considerations
Cancer patients: Continue anticoagulation for at least 6 months, then indefinitely while cancer is active, metastatic, or you're receiving chemotherapy 5. You may use either full-dose or reduced-dose Eliquis for extended treatment.
Reassessment: Your doctor should reevaluate your need for continued anticoagulation at least annually, considering your bleeding risk, burden of taking medication, and any changes in your health status 1, 2.
If you decide to stop: Consider taking aspirin to reduce recurrence risk, though it's much less effective than continuing anticoagulation 1, 2. Aspirin prevents about 30% of recurrences while anticoagulation prevents about 90%.
Critical Warnings
Never stop abruptly without medical guidance - stopping anticoagulation suddenly increases stroke and clot risk 3. If transitioning off Eliquis, your doctor may bridge you with another anticoagulant 3.
The evidence shows that for unprovoked clots, the benefit of preventing life-threatening recurrent clots with reduced-dose extended therapy outweighs bleeding risks for most patients 1, 6, 2. Studies followed patients for up to 4 years on extended therapy, though the optimal duration beyond this timeframe remains uncertain 1.